NCT03062150View on ClinicalTrials.gov

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

NACompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 27, 2016

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Major Depression
Interventions
DRUG

Placebo

Placebo

DRUG

Fludrocortisone

Fludrocortisone

DRUG

D-Cycloserine

D-Cycloserine

Trial Locations (1)

12203

Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

NeuroCure Clinical Research Center, Charite, Berlin

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT03062150 - Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression | Biotech Hunter | Biotech Hunter